ELDN (Eledon Pharmaceuticals, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by ELDN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Steven Perrin | President | MIXED | — | — |
| 2026-08-04 | David-Alexandre C Gros | Chief Executive Officer | MIXED | — | — |
| 2026-01-16 | John S. McBride | Director | M | — | — |
| 2026-01-16 | June Lee | Director | M | — | — |
| 2026-01-16 | Jan Hillson | Director | M | — | — |
| 2026-01-16 | Keith Katkin | Director | M | — | — |
| 2026-01-16 | James A. Robinson Jr. | Director | M | — | — |
| 2026-01-16 | Allan Kirk | Director | M | — | — |
| 2025-01-13 | June Lee | Director | A | — | — |
| 2025-01-13 | Paul Sean Little | Chief Financial Officer | A | — | — |
| 2025-01-13 | Bryan E. Smith | General Counsel, Corporate Sec | A | — | — |
| 2025-01-13 | John S. McBride | Director | A | — | — |
| 2025-01-13 | James A. Robinson Jr. | Director | A | — | — |
| 2025-01-13 | Jan Hillson | Director | A | — | — |
| 2025-01-13 | Allan Kirk | Director | A | — | — |
| 2025-01-13 | Keith Katkin | Director | A | — | — |
| 2025-01-13 | Steven Perrin | President | A | — | — |
| 2025-01-13 | David-Alexandre C Gros | Chief Executive Officer | A | — | — |
| 2024-11-22 | David-Alexandre C Gros | Chief Executive Officer | A | — | — |
| 2024-11-22 | Steven Perrin | President | A | — | — |
| 2024-11-22 | Bryan E. Smith | General Counsel, Corporate Sec | A | — | — |
| 2024-11-22 | Paul Sean Little | Chief Financial Officer | A | — | — |
| 2024-10-31 | BVF INC/IL | 10%+ Owner | Buy | — | — |
| 2024-06-14 | Steven Perrin | President | A | — | — |
| 2024-06-14 | David-Alexandre C Gros | Chief Executive Officer | A | — | — |
| 2024-06-14 | Bryan E. Smith | General Counsel, Corporate Sec | A | — | — |
| 2024-06-14 | Paul Sean Little | Chief Financial Officer | A | — | — |
| 2024-05-13 | BVF PARTNERS L P/IL | 10%+ Owner | Buy | — | — |
| 2023-10-03 | James A. Robinson Jr. | Director | A | — | — |
| 2023-10-03 | Allan Kirk | Director | A | — | — |
| 2023-05-09 | BVF Partners OS Ltd. | — | Buy | — | — |
| 2023-05-02 | John S. McBride | Director | A | — | — |
| 2023-05-02 | Jan Hillson | Director | A | — | — |
| 2023-05-02 | Bryan E. Smith | General Counsel, Corporate Sec | A | — | — |
| 2023-05-02 | Steven Perrin | President | A | — | — |
| 2023-05-02 | Paul Sean Little | Chief Financial Officer | A | — | — |
| 2023-05-02 | Walter C Ogier | Director | A | — | — |
| 2023-05-02 | David-Alexandre C Gros | Chief Executive Officer | A | — | — |
| 2023-05-02 | GARY A LYONS | Director | A | — | — |
| 2023-05-02 | Keith Katkin | Director | A | — | — |
| 2023-05-02 | June Lee | Director | A | — | — |
| 2023-02-02 | John S. McBride | Director | A | — | — |
| 2023-02-02 | Walter C Ogier | Director | A | — | — |
| 2023-02-02 | GARY A LYONS | Director | A | — | — |
| 2023-02-02 | Jan Hillson | Director | A | — | — |
| 2023-02-02 | David-Alexandre C Gros | Chief Executive Officer | A | — | — |
| 2023-02-02 | Paul Sean Little | Chief Financial Officer | A | — | — |
| 2023-02-02 | Keith Katkin | Director | A | — | — |
| 2023-02-02 | Steven Perrin | President | A | — | — |
| 2023-02-02 | Bryan E. Smith | General Counsel, Corporate Sec | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 3,361,803 | — |
| — | 10%+ Owner | 2,633,679 | — |
| — | Chief Executive Officer | 363,454 | — |
| — | — | 145,029 | — |
| — | President | 81,215 | — |
| — | Chief Financial Officer | 10,000 | — |
| — | Director | 8,575 | — |
| — | Director | 3,430 | — |
| — | Director | 3,430 | — |
| — | Director | 3,430 | — |
| — | Director | 3,430 | — |
| — | Director | 3,430 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ELDN quote page; the site-wide leaderboard is on the insider transactions hub.